DarioHealth (DRIO)
(Delayed Data from NSDQ)
$1.00 USD
-0.12 (-10.71%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.01 +0.01 (1.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
DRIO 1.00 -0.12(-10.71%)
Will DRIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for DRIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DRIO
Zacks.com featured highlights include TAL Education, The RealReal, DarioHealth, HealthEquity and Energous
Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains
DRIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
DarioHealth Corp. (DRIO) Q2 Earnings Beat Estimates
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
Other News for DRIO
DarioHealth announces a new contract with a national Medicare Advantage plan
Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
DarioHealth's cardiometabolic solution in diabetes featured in published study
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DarioHealth price target lowered by $2 at TD Cowen, here's why